AKT1 and cholangiocarcinoma: S1P and conjugated bile acids activate the ERK/AKT pathway through the sphingosine 1-phosphate receptor 2 (S1P2 receptor), and among which S1PR2 is the predominant S1P receptor expressed in human CCA cell lines and tissues [23-25].